Browsing Category
Growth Stocks
5 Dividend Stocks to Boost Portfolio Growth – May 15, 2024
The stock market has experienced some ups and downs recently, with concerns about inflation, Fed rate cuts, and a slowing economy weighing on investors' minds. In light of this,…
Read More...
Read More...
2 Growth Stocks That Are Proving the Bears Wrong
Investors who remained loyal to certain companies are now reaping the rewards. Every company faces challenges at some point, leading some investors to sell their stocks in fear of…
Read More...
Read More...
2 Growth Stocks That Are Proving the Bears Wrong
Every company faces challenges at some point, leading some investors to lose faith and sell their stocks. However, there are companies that can overcome these challenges and emerge…
Read More...
Read More...
Up 275% in a year, this defence stock’s growth is just getting started
India's defence sector has undergone a significant transformation in recent years, with a shift towards self-reliance and domestic manufacturing. The country's heavy reliance on…
Read More...
Read More...
3 Growth Stocks Under $200 to Buy and Hold Forever — TradingView News
Investing in growth stocks in rapidly evolving sectors with promising outlooks, such as technology, artificial intelligence (AI), healthcare, cannabis, or renewable energy, can…
Read More...
Read More...
4 US Growth Stocks Punching Through Their All-Time Highs: Can Their Run Continue?
It’s always an exciting feeling when a stock you own hits an all-time high. Even if you do not own the stock, seeing its share price hit a new record suggests that the business is…
Read More...
Read More...
freee K.K Leads Trio Of High Insider Ownership Growth Stocks On Japanese Exchange
In the midst of global market optimism tinged with caution, Japan's Nikkei 225 and TOPIX indices have experienced slight weekly losses, reflecting a mix of economic indicators and…
Read More...
Read More...
Ardelyx (NASDAQ:ARDX): A Commercial-Stage Biopharma Stock with Growth Potential
Ardelyx (NASDAQ: ARDX) has been gaining attention from investors due to the successful launch of two FDA-approved commercial products, IBSRELA® and XPHOZAH®. These products offer…
Read More...
Read More...
3 High Insider Ownership German Stocks With Earnings Growth Up To 33%
In the midst of a positive outlook in European markets, particularly with Germany's DAX index showing significant gains, investors are focusing on opportunities within this…
Read More...
Read More...
2 No-Brainer Growth Stocks Down 29% and 22% to Buy Hand Over Fist Right Now
Many investors are reevaluating stocks as major stock market indices reach new highs. It's important to remember that the stock market is cyclical, with both bear and bull markets…
Read More...
Read More...